1. Organising screening programmes
In the context of an organised screening programme, the ECIBC's Guidelines Development Group (GDG) suggests:
- using double reading (with consensus or arbitration for discordant readings) to screen mammograms for early detection of breast cancer (conditional recommendation, moderate certainty of the evidence)
- mammography readers read between 3 500 and 11 000 mammograms annually (conditional recommendation, very low certainty of the evidence)
Double vs. single reading in mammograpy screening
Issued on: November 2017
Healthcare question
Should double reading (with consensus or arbitration for discordant readings) vs. single reading be used to screen mammograms for early detection of breast cancer in organised population-based screening programmes?
Recommendation
The ECIBC's Guidelines Development Group (GDG) suggests using double reading (with consensus or arbitration for discordant readings) over single reading to screen mammograms for early detection of breast cancer in organised population-based screening programmes.
Recommendation strength
| Conditional recommendation |
| Moderate certainty of the evidence |
Justification
The GDG suggests by consensus that double reading (with consensus or arbitration) over single reading be used to diagnose breast cancer in mammography screening.
Only one study with digital mammography was included in the evidence, which limited the GDG to be able to issue a strong recommendation.
Subgroup considerations
The GDG notes that in the context of double reading with consensus or arbitration, no differences were observed in accuracy when arbitration or consensus or both were used to reconcile differences in interpretation between mammography readers.
Considerations for implementation and policy making
- In settings with many low-volume mammography readers, the balance of benefits and harms may be even greater. The GDG refers readers to the PICO Question 7: ‘What is the optimal annual interpretive volume for radiologists reading screening mammograms?’ in the CCIB report, addressed by the QASDG regarding the experience level of mammography readers.
- In some settings, capacity (human resources of mammography readers) should be scaled up to implement double readings. In settings where double readings are already in practice, the GDG suggests continued use of double readings with consensus or arbitration.
- The GDG notes that a consideration that can favour double reading with consensus or arbitration is in those settings with many low volume mammography readers; the desirable effects of double reading with consensus or arbitration were found to be greater with less undesirable effects in these settings as compared to high volume mammography reader settings.
Monitoring and evaluation
The GDG suggests reporting the proportion of double reading with consensus or arbitration of mammograms that occur in practice. The GDG refers this suggestion to the QASDG for consideration.
Research priorities
- The GDG suggests further research examining the cost-effectiveness of double vs single reading of digital mammography in different settings. Cost-effectiveness data was only identified for Spain.
- The GDG suggests new research using observational studies comparing double reading with consensus or arbitration with single reading in the context of digital mammography. Additional research could also be performed to assess accuracy within the context of double readings assessing a single reader vs with the addition of a second reader, which is performed in practice.
- The GDG suggests the use of formal radiologist blinding in research to improve the quality of evidence on double vs single readings.
- The GDG notes that newer screening strategies such as digital breast tomosynthesis (DBT) or automatic computer assisted detection (CAD) was excluded from the analysis of this question with double vs single mammography. Future research could assess the impact of double reading using CAD and/or DBT systems.
Supporting material
- Organised vs. non-organised screening
- Double vs. single reading in mammograpy screening
- Communication skills training
- Communication with care providers
- Optimal number of mammography readings
- Specialised training
- Risk stratification
- Women aged 40-44: screening vs. no screening
- Women aged 45-49: screening vs. no screening
- Women aged 45-49: annual vs. biennial screening
- Women aged 45-49: annual vs. triennial screening
- Women aged 45-49: triennial vs. biennial screening
- Women aged 50-69: screening vs. no screening
- Women aged 50-69: annual vs. biennial screening
- Women aged 50-69: annual vs. triennial screening
- Women aged 50-69: triennial vs. biennial screening
- Women aged 70-74: screening vs. no screening
- Women aged 70-74: annual vs. biennial screening
- Women aged 70-74: annual vs. triennial screening
- Women aged 70-74: triennial vs. biennial screening
- Single reading with AI support
- Double reading with AI support
- Screening with tomosynthesis vs. mammography
- Screening with tomosynthesis plus mammography vs. mammography alone
- Tailored screening with tomosynthesis
- Screening with tomosynthesis vs. mammography
- Tailored screening with MRI
- Tailored screening with ABUS
- Tailored screening with HHUS
- Informing about benefits and harms: use of decision aids
- Informing about benefits and harms: Numbers in addition to plain language
- Informing about benefits and harms: Infographics in addition to plain language
- Informing about benefits and harms: Story telling in addition to plain language
- Inviting women to screening: letter vs. no invitation
- Inviting socially disadvantaged women to screening: Targeted vs. general communication strategy
- Inviting women with an intellectual disability to screening
- Inviting non-native speakers to screening
- Inviting socially disadvantaged women to screening: Tailored vs. targeted communication strategy
- Inviting socially disadvantaged women to screening: Tailored vs. general communication strategy
- Inviting women to subsequent screening rounds: letter vs. no invitation
- Inviting women to screening: letter with fixed appointment vs. letter
- Inviting women to subsequent screening rounds: letter with fixed appointment vs. lett
- Inviting women to screening: letter with GP signature vs. letter
- Inviting women to subsequent screening rounds: letter with GP signature vs. letter
- Inviting women to screening: letter followed by phone call vs. letter
- Inviting women to subsequent screening rounds: letter followed by phone call vs. letter
- Inviting women to screening: letter followed by phone call vs. no invitation
- Inviting women to screening: letter followed by written reminder vs. letter
- Inviting women to subsequent screening rounds: letter followed by written reminder vs. letter
- Inviting women to screening: letter followed by face to face intervention vs. letter
- Inviting women to subsequent screening rounds: letter followed by face to face intervention vs. letter
- Inviting women to screening: e-mail vs. letter
- Inviting women to screening: automated telephone call vs. letter
- Inviting women to screening: letter followed by automated telephone call vs. letter
- Inviting women to screening: letter followed by SMS notification vs. letter
- Inviting women to screening: letter followed by personalised phone call vs. automated phone call
- Negative result: letter vs. nothing
- Further assessment: letter followed by a phone call
- Further assessment: timing of results
- Negative result: phone call vs. letter
- Negative result: face to face interview vs. letter
- Negative result: timing of results
- Tomosynthesis vs. assessment mammography
- Obtaining a sample from a suspicious breast lesion
- Type of guidance for needle core biopsy
- Stage 1: conventional exams
- Stage 1: PET-CT exams
- Stage 2: conventional exams
- Stage 2: PET-CT exams
- Stage 3: conventional exams
- Stage 3: PET-CT exams
- Stage 3: conventional exams plus PET-CT
- Use of clip-marking
- Additional magnetic resonance imaging
- Contrast-enhanced mammography
- Threshold of oestrogen for endocrine therapy
- Threshold of progesterone for endocrine therapy
- Multigene testing: 70 gene signature at low clinical risk
- Multigene testing: 70 gene signature at high clinical risk
- Multigene testing: 21 gene recurrence score
- Organising screening programmes
- Risk stratification
- Women 40-44
- Women 45-49
- Women 50-69
- Women 70-74
- Women with high breast density
- General Population
- Vulnerable Population
- Informing women about their results
- Women recalled due to suspicious lesions
- Obtaining a sample from a suspicious lesion
- Type of guidance for needle core biopsy
- Stage 1
- Stage 2
- Stage 3
- Planning surgical treatment
- Hormone receptor to guide use of endocrine therapy
- Multigene testing to guide use of chemotherapy